AKCEA THERAPEUTICS INC - COM (AKCA)

CUSIP: 00972L107

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
20,898,680
Share change
-1,092,105
Total reported value
$354,017,237
Put/Call ratio
173%
Price per share
$16.94
Number of holders
74
Value change
-$16,788,985
Number of buys
44
Number of sells
22

Quarterly Holders Quick Answers

What is CUSIP 00972L107?
CUSIP 00972L107 identifies AKCA - AKCEA THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AKCEA THERAPEUTICS INC - COM (AKCA) as of Q4 2019

As of 31 Dec 2019, AKCEA THERAPEUTICS INC - COM (AKCA) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,898,680 shares. The largest 10 holders included FMR LLC, Bellevue Group AG, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and ALPS ADVISORS INC. This page lists 74 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.